Comments
Loading...

Pfizer Analyst Ratings

PFENYSE
Logo brought to you by Benzinga Data
$24.30
At close: Jun 11 EDT
$24.31
0.010.04%
Pre-Market: 8:09 AM EDT
Consensus Rating1
Neutral
Highest Price Target1
$50.00
Lowest Price Target1
$24.00
Consensus Price Target1
$33.32

Pfizer Analyst Ratings and Price Targets | NYSE:PFE | Benzinga

Pfizer Inc has a consensus price target of $33.32 based on the ratings of 24 analysts. The high is $50 issued by HSBC on July 14, 2023. The low is $24 issued by Cantor Fitzgerald on April 22, 2025. The 3 most-recent analyst ratings were released by UBS, Cantor Fitzgerald, and UBS on April 30, 2025, April 22, 2025, and April 8, 2025, respectively. With an average price target of $24.33 between UBS, Cantor Fitzgerald, and UBS, there's an implied 0.10% upside for Pfizer Inc from these most-recent analyst ratings.

Analyst Trends and Forecast
1
Dec 24
2
Jan
1
1
Feb
2
Mar
4
Apr
Buy
Hold
Sell
Strong Sell
Analyst Rating and Forecast
12345
2.6
Hold
Strong Buy
Buy
Hold
Sell
Strong Sell

Analyst Firms Making Recommendations1

UBS
Cantor Fitzgerald
Goldman Sachs
UBS
Citigroup

1calculated from analyst ratings

Analyst Ratings for Pfizer

Buy NowGet Alert
04/30/2025Buy Now2.84%UBS
Trung Huynh70%
$24 → $25MaintainsNeutralGet Alert
04/22/2025Buy Now-1.28%Cantor Fitzgerald
Carter Gould56%
→ $24Initiates → NeutralGet Alert
04/08/2025Buy Now-1.28%UBS
Trung Huynh70%
$28 → $24MaintainsNeutralGet Alert
04/08/2025Buy Now2.84%Goldman Sachs
Asad Haider 57%
$32 → $25DowngradeBuy → NeutralGet Alert
03/18/2025Buy NowGuggenheim
Vamil Divan73%
ReiteratesBuy → BuyGet Alert
03/12/2025Buy NowGuggenheim
Vamil Divan73%
ReiteratesBuy → BuyGet Alert
02/10/2025Buy Now35.75%Guggenheim
Vamil Divan73%
$33 → $33ReiteratesBuy → BuyGet Alert
02/05/2025Buy Now15.18%UBS
Colin Bristow39%
$29 → $28MaintainsNeutralGet Alert
01/28/2025Buy Now19.29%Citigroup
Andrew Baum70%
$30 → $29MaintainsNeutralGet Alert
01/08/2025Buy Now19.29%UBS
Colin Bristow39%
$31 → $29MaintainsNeutralGet Alert
12/18/2024Buy Now31.63%Truist Securities
Srikripa Devarakonda44%
$36 → $32MaintainsBuyGet Alert
12/11/2024Buy Now35.75%Guggenheim
Vamil Divan73%
$35 → $33MaintainsBuyGet Alert
12/10/2024Buy Now19.29%B of A Securities
Tim Anderson63%
→ $29Reinstates → NeutralGet Alert
11/15/2024Buy Now2.84%Wolfe Research
Alexandria Hammond48%
→ $25Initiates → UnderperformGet Alert
10/30/2024Buy Now27.52%Morgan Stanley
Terence Flynn65%
$30 → $31MaintainsEqual-WeightGet Alert
10/25/2024Buy Now85.11%Cantor Fitzgerald
Louise Chen57%
$45 → $45ReiteratesOverweight → OverweightGet Alert
10/23/2024Buy Now85.11%Cantor Fitzgerald
Louise Chen57%
$45 → $45ReiteratesOverweight → OverweightGet Alert
10/17/2024Buy Now31.63%Bernstein
Courtney Breen1%
→ $32Initiates → Market PerformGet Alert
10/11/2024Buy Now23.4%Morgan Stanley
Terence Flynn65%
$31 → $30MaintainsEqual-WeightGet Alert
10/03/2024Buy Now85.11%Cantor Fitzgerald
Louise Chen57%
$45 → $45ReiteratesOverweight → OverweightGet Alert
09/16/2024Buy Now85.11%Cantor Fitzgerald
Louise Chen57%
$45 → $45ReiteratesOverweight → OverweightGet Alert
09/09/2024Buy Now85.11%Cantor Fitzgerald
Louise Chen57%
$45 → $45ReiteratesOverweight → OverweightGet Alert
08/19/2024Buy Now85.11%Cantor Fitzgerald
Louise Chen57%
$45 → $45ReiteratesOverweight → OverweightGet Alert
08/08/2024Buy Now39.86%Daiwa Capital
Narumi Nakagiri22%
$28 → $34UpgradeNeutral → OutperformGet Alert
07/31/2024Buy Now27.52%Morgan Stanley
Terence Flynn65%
$29 → $31MaintainsEqual-WeightGet Alert
07/31/2024Buy Now31.63%Barclays
Carter Gould56%
$30 → $32MaintainsEqual-WeightGet Alert
07/31/2024Buy Now23.4%Wells Fargo
Mohit Bansal67%
$28 → $30MaintainsEqual-WeightGet Alert
07/31/2024Buy Now85.11%Cantor Fitzgerald
Louise Chen57%
$45 → $45ReiteratesOverweight → OverweightGet Alert
07/31/2024Buy Now27.52%UBS
Colin Bristow39%
$30 → $31MaintainsNeutralGet Alert
07/12/2024Buy Now23.4%UBS
Colin Bristow39%
$28 → $30MaintainsNeutralGet Alert
07/10/2024Buy Now23.4%Barclays
Carter Gould56%
$28 → $30MaintainsEqual-WeightGet Alert
07/10/2024Buy Now85.11%Cantor Fitzgerald
Louise Chen57%
$45 → $45ReiteratesOverweight → OverweightGet Alert
07/01/2024Buy Now85.11%Cantor Fitzgerald
Louise Chen57%
$45 → $45ReiteratesOverweight → OverweightGet Alert
06/26/2024Buy Now85.11%Cantor Fitzgerald
Louise Chen57%
$45 → $45ReiteratesOverweight → OverweightGet Alert
06/20/2024Buy Now85.11%Cantor Fitzgerald
Louise Chen57%
$45 → $45ReiteratesOverweight → OverweightGet Alert
06/17/2024Buy Now85.11%Cantor Fitzgerald
Louise Chen57%
$45 → $45ReiteratesOverweight → OverweightGet Alert
05/02/2024Buy Now19.29%Morgan Stanley
Terence Flynn65%
$28 → $29MaintainsEqual-WeightGet Alert
05/02/2024Buy Now48.09%BMO Capital
Evan David Seigerman48%
$33 → $36ReiteratesOutperform → OutperformGet Alert
04/18/2024Buy Now85.11%Cantor Fitzgerald
Louise Chen57%
$45 → $45ReiteratesOverweight → OverweightGet Alert
04/15/2024Buy Now85.11%Cantor Fitzgerald
Louise Chen57%
$45 → $45ReiteratesOverweight → OverweightGet Alert
04/05/2024Buy Now85.11%Cantor Fitzgerald
Louise Chen57%
$45 → $45ReiteratesOverweight → OverweightGet Alert
04/01/2024Buy Now85.11%Cantor Fitzgerald
Louise Chen57%
$45 → $45ReiteratesOverweight → OverweightGet Alert
03/31/2024Buy Now19.29%Morgan Stanley
Terence Flynn65%
$28 → $29MaintainsEqual-WeightGet Alert
03/22/2024Buy NowArgus Research
David Toung69%
DowngradeBuy → HoldGet Alert
03/04/2024Buy Now85.11%Cantor Fitzgerald
Louise Chen57%
$45 → $45ReiteratesOverweight → OverweightGet Alert
03/01/2024Buy Now85.11%Cantor Fitzgerald
Louise Chen57%
$45 → $45ReiteratesOverweight → OverweightGet Alert
02/23/2024Buy Now48.09%Guggenheim
Vamil Divan73%
→ $36Initiates → BuyGet Alert
01/31/2024Buy Now15.18%UBS
Colin Bristow39%
$29 → $28MaintainsNeutralGet Alert
01/31/2024Buy Now85.11%Cantor Fitzgerald
Louise Chen57%
$45 → $45ReiteratesOverweight → OverweightGet Alert
01/17/2024Buy Now19.29%UBS
Colin Bristow39%
$27 → $29MaintainsNeutralGet Alert
01/09/2024Buy Now85.11%Cantor Fitzgerald
Louise Chen57%
$45 → $45ReiteratesOverweight → OverweightGet Alert
01/04/2024Buy Now31.63%TD Cowen
Steve Scala67%
→ $32DowngradeOutperform → Market PerformGet Alert
12/14/2023Buy Now15.18%Wells Fargo
Mohit Bansal67%
$35 → $28MaintainsEqual-WeightGet Alert
12/14/2023Buy Now85.11%Cantor Fitzgerald
Louise Chen57%
$75 → $45MaintainsOverweightGet Alert
12/14/2023Buy Now48.09%Truist Securities
Robyn Karnauskas54%
$42 → $36MaintainsBuyGet Alert
12/14/2023Buy Now11.06%UBS
Colin Bristow39%
$34 → $27MaintainsNeutralGet Alert
12/14/2023Buy Now15.18%Barclays
Carter Gould56%
$34 → $28MaintainsEqual-WeightGet Alert
12/04/2023Buy Now72.77%Truist Securities
Robyn Karnauskas54%
→ $42ReiteratesBuy → BuyGet Alert
11/20/2023Buy Now208.51%Cantor Fitzgerald
Louise Chen57%
→ $75ReiteratesOverweight → OverweightGet Alert
11/01/2023Buy Now39.86%Barclays
Carter Gould56%
$35 → $34MaintainsEqual-WeightGet Alert
11/01/2023Buy Now52.2%Morgan Stanley
Terence Flynn65%
$39 → $37MaintainsEqual-WeightGet Alert
10/20/2023Buy Now39.86%UBS
Colin Bristow39%
$36 → $34AssumesNeutral → NeutralGet Alert
10/17/2023Buy Now72.77%Truist Securities
Robyn Karnauskas54%
$62 → $42MaintainsBuyGet Alert
10/17/2023Buy Now60.43%Morgan Stanley
Terence Flynn65%
$40 → $39MaintainsEqual-WeightGet Alert
10/17/2023Buy Now43.97%Wells Fargo
Mohit Bansal67%
$39 → $35MaintainsEqual-WeightGet Alert
10/16/2023Buy Now35.75%BMO Capital
Evan David Seigerman48%
$44 → $33MaintainsOutperformGet Alert
10/16/2023Buy Now43.97%Citigroup
Andrew Baum70%
$42 → $35MaintainsNeutralGet Alert
10/16/2023Buy Now39.86%JP Morgan
Chris Schott59%
$36 → $34MaintainsNeutralGet Alert
10/16/2023Buy Now43.97%Wells Fargo
Mohit Bansal67%
$39 → $35MaintainsEqual-WeightGet Alert
10/16/2023Buy Now60.43%Jefferies
Akash Tewari42%
$38 → $39UpgradeHold → BuyGet Alert
10/06/2023Buy Now48.09%JP Morgan
Chris Schott59%
$39 → $36MaintainsNeutralGet Alert
10/02/2023Buy Now208.51%Cantor Fitzgerald
Louise Chen57%
→ $75ReiteratesOverweight → OverweightGet Alert
09/18/2023Buy Now208.51%Cantor Fitzgerald
Louise Chen57%
→ $75ReiteratesOverweight → OverweightGet Alert
09/13/2023Buy Now155.04%Truist Securities
Robyn Karnauskas54%
→ $62ReiteratesBuy → BuyGet Alert
09/05/2023Buy Now208.51%Cantor Fitzgerald
Louise Chen57%
→ $75ReiteratesOverweight → OverweightGet Alert
08/30/2023Buy Now208.51%Cantor Fitzgerald
Louise Chen57%
→ $75ReiteratesOverweight → OverweightGet Alert
08/22/2023Buy Now208.51%Cantor Fitzgerald
Louise Chen57%
→ $75ReiteratesOverweight → OverweightGet Alert
08/02/2023Buy Now155.04%Truist Securities
Robyn Karnauskas54%
$64 → $62MaintainsBuyGet Alert
08/02/2023Buy Now64.54%Morgan Stanley
Terence Flynn65%
$42 → $40MaintainsEqual-WeightGet Alert
08/02/2023Buy Now80.99%BMO Capital
Evan David Seigerman48%
$45 → $44MaintainsOutperformGet Alert
07/21/2023Buy Now72.77%Morgan Stanley
Terence Flynn65%
$43 → $42MaintainsEqual-WeightGet Alert
07/14/2023Buy Now105.67%HSBC
Rajesh Kumar61%
→ $50Initiates → BuyGet Alert
07/11/2023Buy Now76.88%Morgan Stanley
Terence Flynn65%
$43 → $43ReiteratesEqual-Weight → Equal-WeightGet Alert
07/11/2023Buy Now56.31%Barclays
Carter Gould56%
$40 → $38MaintainsEqual-WeightGet Alert
06/29/2023Buy Now64.54%Credit Suisse
Trung Huynh70%
$47 → $40DowngradeOutperform → NeutralGet Alert
06/23/2023Buy Now208.51%Cantor Fitzgerald
Louise Chen57%
$75 → $75ReiteratesOverweight → OverweightGet Alert
06/22/2023Buy Now208.51%Cantor Fitzgerald
Louise Chen57%
→ $75ReiteratesOverweight → OverweightGet Alert
05/17/2023Buy Now208.51%Cantor Fitzgerald
Louise Chen57%
→ $75ReiteratesOverweight → OverweightGet Alert
05/11/2023Buy Now56.31%Daiwa Capital
Narumi Nakagiri22%
$51 → $38DowngradeOutperform → NeutralGet Alert
05/03/2023Buy Now93.33%Credit Suisse
Trung Huynh70%
$50 → $47MaintainsOutperformGet Alert
05/03/2023Buy Now64.54%Barclays
Carter Gould56%
$43 → $40MaintainsEqual-WeightGet Alert
04/21/2023Buy Now85.11%B of A Securities
Geoff Meacham62%
$50 → $45MaintainsNeutralGet Alert
04/12/2023Buy Now76.88%Barclays
Carter Gould56%
$44 → $43MaintainsEqual-WeightGet Alert
04/10/2023Buy Now80.99%Morgan Stanley
Terence Flynn65%
$45 → $44MaintainsEqual-WeightGet Alert
03/17/2023Buy Now80.99%Wells Fargo
Mohit Bansal67%
$50 → $44MaintainsEqual-WeightGet Alert
03/06/2023Buy Now76.88%Jefferies
Akash Tewari42%
→ $43Initiates → HoldGet Alert
02/07/2023Buy Now109.79%Daiwa Capital
Narumi Nakagiri22%
→ $51UpgradeNeutral → OutperformGet Alert
02/01/2023Buy Now85.11%Morgan Stanley
Terence Flynn65%
$53 → $45MaintainsEqual-WeightGet Alert
02/01/2023Buy Now208.51%Cantor Fitzgerald
Louise Chen57%
→ $75Reiterates → OverweightGet Alert
02/01/2023Buy Now105.67%Credit Suisse
Trung Huynh70%
$54 → $50MaintainsOutperformGet Alert

FAQ

Q

What is the target price for Pfizer (PFE) stock?

A

The latest price target for Pfizer (NYSE:PFE) was reported by UBS on April 30, 2025. The analyst firm set a price target for $25.00 expecting PFE to rise to within 12 months (a possible 2.84% upside). 36 analyst firms have reported ratings in the last year.

Q

What is the most recent analyst rating for Pfizer (PFE)?

A

The latest analyst rating for Pfizer (NYSE:PFE) was provided by UBS, and Pfizer maintained their neutral rating.

Q

When was the last upgrade for Pfizer (PFE)?

A

The last upgrade for Pfizer Inc happened on August 8, 2024 when Daiwa Capital raised their price target to $34. Daiwa Capital previously had a neutral for Pfizer Inc.

Q

When was the last downgrade for Pfizer (PFE)?

A

The last downgrade for Pfizer Inc happened on April 8, 2025 when Goldman Sachs changed their price target from $32 to $25 for Pfizer Inc.

Q

When is the next analyst rating going to be posted or updated for Pfizer (PFE)?

A

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Pfizer, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Pfizer was filed on April 30, 2025 so you should expect the next rating to be made available sometime around April 30, 2026.

Q

Is the Analyst Rating Pfizer (PFE) correct?

A

While ratings are subjective and will change, the latest Pfizer (PFE) rating was a maintained with a price target of $24.00 to $25.00. The current price Pfizer (PFE) is trading at is $24.31, which is within the analyst’s predicted range.

Browse analyst ratings and price targets on all stocks.

People Also Watch